← All Sponsors
SPONSOR

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Total Trials
15
Recruiting
15
Phases
Phase 2, EARLY_Phase 1, Phase 1, Phase 2, Phase 2, Phase 3, Phase 1
NCT06802666 Phase 2
Recruiting

Short-course Radiotherapy Followed by AK112 and CAPOX as Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer
NCT07240974 EARLY_Phase 1
Recruiting

Safety and Efficacy of ZZSW-01 in Relapsed/Refractory B-cell Malignancies

Relapsed/Refractory B-cell Malignancies
NCT06794853
Recruiting

Mechanism of TIPS to Improve Sarcopenia

Sarcopenia
NCT07301827
Recruiting

Study on the Diagnostic Value of Novel PET Molecular Imaging for Renal Cell Carcinoma

Renal Cell Carcinoma
NCT06503094 Phase 1, Phase 2
Recruiting

CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological Tumors

B-Cell Lymphoblastic Leukemia/Lymphoma
NCT06977945
Recruiting

Clinical Application of FL-091 Radionuclide Imaging in Diagnosis and Staging of Malignant Tumors

Malignant Tumors With Positive NTSR1 Expression
NCT06785571 Phase 2, Phase 3
Recruiting

The Evaluation of the Effectiveness and Safety of Nalbuphine Hydrochloride Injection for Analgesia in ICU Patients: A Multicenter, Randomized, Single-blinded, Parallel, Two-step Trial

Respiratory Insufficiency
NCT06140966 Phase 2
Recruiting

Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma

Multiple Myeloma
NCT07101705 EARLY_Phase 1
Recruiting

An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treating Relapsed/Refractory Hematological Malignancies

Multiple Myeloma (MM)
NCT06741995
Recruiting

Evaluating the Prognostic Impact of Anti-β1AR Antibodies and Anti-L-CaC Antibodies in Patients With Dilated Cardiomyopathy

Dilated Cardiomyopathy (DCM)
NCT06693973 EARLY_Phase 1
Recruiting

An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

B-cell Non-Hodgkin Lymphoma (B-NHL)
NCT06463847 Phase 1
Recruiting

Phase I Clinical Trial of UC-MSCs in the Treatment of Knee Osteoarthritis

Knee Osteoarthritis
NCT05131750
Recruiting

RIR and the Impact on Clinical Outcomes in Patients Undergoing PCI

hsCRP
NCT05994274
Recruiting

A Clinical Study of Association Between Postoperative Dyslipidemia and Organ Rejection in Transplant Patients

Heart Transplant Failure and Rejection
NCT06241274
Recruiting

Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT

Moxibustion